Maastricht University Medical Center
Maastricht, Netherlands
NCT Number: NCT06745843
The goal of this study is to investigate digital health literacy in liver cirrhosis patients.
Participants will fill in two questionnaires by email or mail.
Looking for future studies?
Notify Me18 year–18 year
All sexes
Interventional
Not applicable
Maastricht, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patient information, informed consent form and questionnaire will collectively be distributed digitally or by mail to all patients.
Time frame: At time of enrollment, single point in time.
Digital health literacy Instrument (DHLI) 2.0 has 24 self-report items. People score how difficult they perceive certain tasks to be and how often they experience certain problems on the Internet. Each item was scored on a 4-point scale, with response options ranging from "very easy" to "very difficult" and from "never" to "often." Scores are reversed, so that a higher score represented a higher level of digital health literacy.
Time frame: At time of enrollment, single point in time.
This is a questionnaire with items assessing health visualization literacy. People are shown 20 visualizations with information about their disease and answer a question to test if they understood the information in the visualization. The scores consist of number of right answers, so a higher score represent better digital health visualization.
Maastricht University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07701031
Digestive System Diseases, Fibrosis
Münster, Germany
View Trial DetailsNCT06708832
Digestive System Diseases, Fibrosis
Graz, Austria
View Trial DetailsNCT07625085
Digestive System Diseases, Fibrosis
Rome, Lazio, Italy
View Trial DetailsNCT01082419
Adenocarcinoma, Biliary Cholestasis
Bordeaux, France
View Trial Details